China’s Ministry of Health Tightens Organ Transplant Regulations with Expert Conference
Shi Bingyi, a distinguished Member of the National Committee of the CPPCC (Chinese People’s Political...
Shi Bingyi, a distinguished Member of the National Committee of the CPPCC (Chinese People’s Political...
On April 2nd, a landmark healthcare initiative, the “Hypertension Prevention and Treatment Research” project, commenced...
China Biopharma Corporation, trading on the OTC Bulletin Board under the symbol (CBPC.OB), announced a...
Shanghai is advancing towards a significant milestone in pharmaceutical safety with plans to establish the...
In a strategic move to assert the value and historical significance of Traditional Chinese Medicine...
In a strategic response to India’s Ministry of Commerce and Industry’s (MOFCOM) anti-dumping ruling against...
Novartis (NYSE: NVS), a multinational pharmaceutical giant, has reported a robust sales revenue of nearly...
In a significant advancement in endocrine research, scientists within the Endocrine Department at Ruijin Hospital...
China’s State Food and Drug Administration (SFDA) is poised to embrace a new era of...
Since 2007, Guangdong province’s medical facilities have utilized an online procurement system known as “Sunlight...
In a groundbreaking study, Ruijin Hospital’s Endocrine Department researchers identified five novel mutations in 17...
China’s State Food and Drug Administration (SFDA) is gearing up for a transparency overhaul, with...
The China Chamber of Commerce for Import and Export of Medicines and Health Products (CCCMHPIE)...
Shanghai Roche Pharmaceuticals Ltd. made headlines in March with the launch of its lung cancer...